Recruiting

HPV

Sponsor:

Michigan State University

Code:

NCT05984849

Conditions

HPV

Vaccine-Preventable Diseases

Eligibility Criteria

Sex: All

Age: 11 - 14

Healthy Volunteers: Accepted

Interventions

vaccination game

Study Details

Brief summary:

This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.

Conditions

HPV

Vaccine-Preventable Diseases

Study ID

NCT05984849

Start date

Oct 27, 2025

Status verified date

May, 2026

Completion date

Aug 31, 2027

Anticipated

Primary completion date

Jun 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 11 - 14

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Child sample: (1) 11-14 years old, (2) speaks and reads English, (3) has never received any doses of the HPV vaccine, (4) is not currently enrolled in another project that involves HPV-related education, and (5) agrees and provides assent to participate in research activities.
  • Parent sample: (1) parent or legal guardian of the participating child, (2) speak and read English, (3) own a smartphone, (4) agree to receive email and text messages, (5) is not currently enrolled in another project that involves HPV-related education, and (6) agree and provide consent to participate in research activities.

Exclusion Criteria: Individuals who do not meet inclusion criteria or refuse to provide consent/assent.

Study Design

Enrollment

180 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: HPV game group

parent-child dyads receive HPV game intervention

no intervention: Usual care

parent-child dyads receive usual care (no intervention)

Interventions

vaccination game

A health game to promote HPV vaccination among youth

Primary outcome measure

  • Percentage of eligible individuals agreeing to participate [ Time Frame: T0 (occurs after consenting and before assigning to different study conditions) ]
  • Proportion of participants who are retained through follow-up [ Time Frame: T2 (occurs two months after completion of the intervention) ]
  • Percentage of participants who complete the intervention and assessments [ Time Frame: T2 (occurs two months after completion of the intervention) ]
  • Participant satisfaction with the project [ Time Frame: T2 (occurs two months after completion of the intervention) ]
  • Intention to vaccinate the children against HPV [ Time Frame: T0 (occurs after consenting and before assigning to different study conditions); T1 (occurs immediately post intervention);T2 (occurs two months after completion of the intervention) ]

Central Contacts and Locations

Central contacts

ANGELA CHEN, PhD

(517) 884-4645VaccineHealthGame@msu.edu

Nouran Ghonaim, BS

(517) 884-4645VaccineHealthGame@msu.edu

Locations

Community

Recruiting

Chandler, Arizona, United States, 85224

Contacts

ANGELA CHEN

(480) 253-9098Healthandgame@gmail.com

More Information

Sponsor

Michigan State University

Last update posted

May 20, 2026

Last verified

May, 2026

Keywords

  • adolescent
  • game intervention

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Michigan State University on 2026-05-20.